verbenone has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, RM; da Fonsêca, DV; de Almeida, RN; de Farias, IEV; de Luna Freire Pessôa, H; de Melo, CGF; de Sousa, DP; do Amaral, IPG; Filho, MRDC; Lima, EM; Salgado, PRR | 1 |
| Choi, Y; Gu, J; Hwang, S; Ju, C; Kim, C; Kim, M; Kim, WK; Kwon, J; Lee, K; Oh, YK; Song, S | 1 |
2 other study(ies) available for verbenone and Disease Models, Animal
| Article | Year |
|---|---|
Anticonvulsive activity of (1S)-(-)-verbenone involving RNA expression of BDNF, COX-2, and c-fos.
Topics: Animals; Anticonvulsants; Bicyclic Monoterpenes; Brain-Derived Neurotrophic Factor; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Male; Mice; Pentylenetetrazole; Pilocarpine; Proto-Oncogene Proteins c-fos; RNA, Messenger; Seizures; Terpenes; Up-Regulation | 2017 |
Discovery of novel (1S)-(-)-verbenone derivatives with anti-oxidant and anti-ischemic effects.
Topics: Animals; Antioxidants; Bicyclic Monoterpenes; Cells, Cultured; Disease Models, Animal; Drug Discovery; Ischemia; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxidative Stress; Terpenes | 2013 |